Resources

Type of publications
Regions
Diseases
4864 results found
2016 ∙ La Torre, G. Mannocci, A. Saulle, R. Colamesta, V. Meggiolaro, A. Mipatrini, D. Sinopoli, A.
Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013)
All age groups Hepatitis B Economic aspects Coverage
Rating:
Not applicable
2016 ∙ Gibson, E. Begum, N. Sigmundsson, B. Sackeyfio, A. Hackett, J. Rajaram, S.
Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review
All age groups Influenza Rotavirus Meningococcal disease Pneumococcal disease Human papillomavirus (HPV) Hepatitis B Varicella Economic aspects
Rating:
Not applicable
2016 ∙ Chit, A. Lee, J. K. Shim, M. Nguyen, V. H. Grootendorst, P. Wu, J. Van Exan, R. Langley, J. M.
Economic evaluation of vaccines in Canada: A systematic review
Americas Canada All age groups Economic aspects
Rating:
Not applicable
2016 ∙ Interaminense, I. N. C. S., de Oliveira, S. C., Leal, L. P., Linhares, F. M. P., Pontes, C. M.
Educational technologies to promote vaccination against human papillomavirus: Integrative literature review
Adolescents Adults Human papillomavirus (HPV) Acceptance
Rating:
Not applicable
2016 ∙ Liao, Z. Xu, X. Liang, Y. Xiong, Y. Chen, R. Ni, J.
Effect of a booster dose of influenza vaccine in patients with hemodialysis, peritoneal dialysis and renal transplant recipients: A systematic literature review and meta-analysis
Adults Older adults Influenza Efficacy/effectiveness Administration
Rating:
Critically low
2016 ∙ Lall, D. Cason, E. Pasquel, F. J. Ali, M. K. Narayan, K. M. V.
Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low-and Middle-Income Countries
All age groups Low and Middle Income Countries Influenza Efficacy/effectiveness Coverage Economic aspects
Rating:
Critically low
2016 ∙ Santos, V. S. Marques, D. P. Martins-Filho, P. R. Cuevas, L. E. Gurgel, R. Q.
Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis
Americas Newborn Children Low and Middle Income Countries Rotavirus Efficacy/effectiveness
Rating:
Critically low
2016 ∙ Remschmidt, C. Harder, T. Wichmann, O. Bogdan, C. Falkenhorst, G.
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: A systematic review
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety
Rating:
High
2016 ∙ Diao, W. Q. Shen, N. Yu, P. X. Liu, B. B. He, B.
Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials
Adolescents Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2016 ∙ Schiffner-Rohe, J. Witt, A. Hemmerling, J. Von Eiff, C. Leverkus, F. W.
Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk - A systematic review and meta-analysis
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
Loading...